Literature DB >> 500521

The pharmacokinetics of oral and intravenous metronidazole in man.

G W Houghton, J Smith, P S Thorne, R Templeton.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 500521     DOI： 10.1093/jac/5.5.621

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  13 in total

1.  Disposition of metronidazole and its effects on sulphasalazine metabolism in patients with inflammatory bowel disease.

Authors:  J L Shaffer; A Kershaw; J B Houston
Journal:  Br J Clin Pharmacol       Date:  1986-04       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of metronidazole.

Authors:  E D Ralph
Journal:  Clin Pharmacokinet       Date:  1983 Jan-Feb       Impact factor: 6.447

3.  A comparison of the pharmacokinetics of metronidazole in man after oral administration of single doses of benzoylmetronidazole and metronidazole.

Authors:  G W Houghton; H K Hundt; F O Muller; R Templeton
Journal:  Br J Clin Pharmacol       Date:  1982-08       Impact factor: 4.335

Review 4.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 5.  Treatment of infections caused by metronidazole-resistant Trichomonas vaginalis.

Authors:  Sarah L Cudmore; Kiera L Delgaty; Shannon F Hayward-McClelland; Dino P Petrin; Gary E Garber
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

6.  Determining population and developmental pharmacokinetics of metronidazole using plasma and dried blood spot samples from premature infants.

Authors:  Michael Cohen-Wolkowiez; Mario Sampson; Barry T Bloom; Antonio Arrieta; James L Wynn; Karen Martz; Barrie Harper; Gregory L Kearns; Edmund V Capparelli; David Siegel; Daniel K Benjamin; P Brian Smith
Journal:  Pediatr Infect Dis J       Date:  2013-09       Impact factor: 2.129

7.  Influence of dose and route of administration on disposition of metronidazole and its major metabolites.

Authors:  S Loft; M Døssing; H E Poulsen; J Sonne; K L Olesen; K Simonsen; P B Andreasen
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Disposition of oral metronidazole in hepatic cirrhosis and in hepatosplenic schistosomiasis.

Authors:  T K Daneshmend; M Homeida; C M Kaye; A A Elamin; C J Roberts
Journal:  Gut       Date:  1982-10       Impact factor: 23.059

9.  The penetration of metronidazole into synovial fluid.

Authors:  M A Sattar; M G Sankey; M I Cawley; C M Kaye; J E Holt
Journal:  Postgrad Med J       Date:  1982-01       Impact factor: 2.401

Review 10.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.